Senzime reports completion of trial
Uppsala, January 12, 2017. Senzime AB (publ) reports completion of the initial volunteer study performed at the Mayo Clinic in the USA. The study evaluated the ease of use, required set-up time, and volunteer comfort during testing using Senzime’s patient neuromonitoring system, the TetraGraph.Senzime, in collaboration with the principal investigator Dr. J. Ross Renew, a recognized researcher in the area of neuromuscular pharmacology and physiology at Mayo Clinic’s Florida USA location in Jacksonville carried out a validation study in volunteers to evaluate TetraGraph’s ease of use,